ArticlePlants (Basel, Switzerland)2026
Safety Assessment of Selenium-Biofortified Broccoli Seedlings: Insights from Repeated-Dose Toxicity and Genotoxicity Evaluation in Mice.
Article in Plants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Selenium (Se) is an essential trace element; however, excessive exposure may cause adverse effects because of its narrow safety margin. This study evaluated the toxicological and genotoxic effects of Se-biofortified broccoli seedlings in male and female Swiss mice. Animals received control or Se-enriched broccoli seedlings orally for 40 days (15, 45, or 70 µg Se/kg body weight (BW)). General toxicity (body weight gain), hematological (complete blood count), biochemical (creatinine, bilirubin, aspartate aminotransferase, alanine aminotransferase, and urea), histopathological, and micronucleus evaluations were performed. No significant changes in body weight or hematological parameters were detected. Biochemical alterations were restricted to males, with increased urea (51.90 ± 2.14 mg/dL) and decreased aspartate aminotransferase (128.4 ± 14.45 U/L) after 45 µg Se/kg BW. The highest Se dose increased spleen (0.60 ± 0.04 g/100 g BW) and ovary (0.29 ± 0.03 g/100 g BW) weights in females, decreased liver weight (5.82 ± 0.10 g/100 g BW), increased testis weight (0.76 ± 0.04 g/100 g BW) in males, induced renal and splenic histological alterations, and increased micronucleated polychromatic erythrocytes (0.46 ± 0.04). These findings indicate that 15 µg Se/kg BW was the safest dose evaluated. Future studies should investigate Se speciation and sex-dependent toxicological responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.